Dermata Therapeutics, Inc. (DRMA)
↓ Download CSVKey ratios (FY2025)
-121.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$7.77M | -$12.51M | -$8.04M | -$9.67M | -$7.86M | -$3.17M | — |
| Net Income | -$7.56M | -$12.29M | -$7.79M | -$9.61M | -$7.90M | -$3.24M | — |
| EPS (Diluted) | $-8.16 | $-80.32 | $-39.99 | $-13.92 | $-2.43 | $-1.69 | — |
| Total Assets | $7.86M | $3.53M | $7.98M | $6.94M | $11.62M | $605.5K | — |
| Total Liabilities | $1.64M | $1.97M | $1.62M | $922.6K | $1.52M | $3.78M | — |
| Shareholders' Equity | $6.22M | $1.56M | $6.36M | $6.02M | $10.11M | -$3.18M | -$210.2K |
| Cash & Equivalents | $7.52M | $3.16M | — | $6.24M | $10.80M | $530.4K | — |
| Operating Cash Flow | -$7.76M | -$11.16M | -$6.41M | -$8.83M | -$5.69M | -$4.03M | — |
| Shares Outstanding | 2.66M | 251.7K | 262.0K | 770.1K | 8.33M | — | — |